The California Board of Pharmacy has announced that it will delay implementation of its electronic pedigree requirements until 2011.
Pharmaceutical companies, wholesalers, and pharmacies breathed a sigh of relief as the California Board of Pharmacy voted to delay implementation of its
Q&A: Factors Showing Tirzepatide is More Beneficial Than Semaglutide | ASHP Midyear
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed the benefits of tirzepatide compared with semaglutide.